Role of T cells in the adjuvant effect of Bacillus firmus on the immune system of mice: Intranasal and intratracheal immunization study with ovalbumin

Folia Microbiologica

Volumn 48, Issue 3, 2003, Pages 427-434

  Mlckova P ^a   Cechova D ^a   Maruskova L ^a   Chalupna P ^a   Novotna O ^a   Prokesova L ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BACILLUS FIRMUS; BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 0042887672     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931379     Document Type: Article

References (33)

1. CARUSO A., FLAMMINIO G., FOLGHERA S., PERONI L., FORESTI I., BALSARI A., TURANO A.: Expression of activation markers on peripheral-blood lymphocytes following oral administration of Bacillus subtilis spores. Internat.J.Immunopharmacol. 15, 87-92 (1993).
2. ELSON C.A., EALDING W.: Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J.Immunol. 132, 2736-2741 (1984).
3. GAO J., CARUSO A., FRANCESCO M., CANARIS A.D., LICENZIATI S., CORULLI M., DIMA F., FALLACARA F., SAVIO L., MARTINELLI F., FIORENTINI S., GARGIULD F., TURANO A.: Heat-killed Bacillus subtilis inhibits T-cell proliferative response to mitogens and recall antigens. Internat.J.Immunopharmacol. 18, 701-706 (1996).
4. HESSLE C., ANDERSON B., WOLD A.E.: Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while Gram-negative bacteria preferentially stimulate IL-10 production. Infect.Immun. 68, 3581-3586 (2000).
5. HODGE L.M., MARINARO M., JONES H.P., MCGHEE J.R., KIYONO H., SIMECKA J.W.: Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization. Infect. Immun. 69, 2328-2338 (2001).
6. HOLT P.G., OLIVER J., BILYK N., MCMENAMIN C., MCMENAMIN P.G., KRAAL G., THEPEN T.: Downregulation of the antigen presenting cells function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J.Exp.Med. 177, 397-407 (1993).
7. KAWABE T., ISOBE K.L., HASEGAWA Y., NAKASHIMA I., SHIMOKATA K.: Immunosuppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages. Immunology 76, 72-78 (1992).
8. KWEON M.N., YAMAMOTO M., WATANABE F., TAMURA S., VAN GINKEL F.W., MIYAUCHI A., TAKAGI H., TAKEDA Y., HAMABATA T., FUJIHASHI K., MCGHEE J.R., KIYONO H.: A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies. J.Infect.Dis. 186, 1261-1269 (2002).
9. LAMBRECHT B.N., PAUWELS R.A., ST.GROTH B.F.: Induction of rapid T cell activation, division, and recirculation by intratracheal injection of dendritic cells in a TCR transgenic model. J.Immunol. 164, 2937-2946 (2000).
10. H1 cells activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur.J.Immunol. 21, 2489-2494 (1991).
11. MÁRA M., JULÁK J., MENČÍKOVÁ E., OČENÁSKOVÁ J., DOHNALOVA Á.: Effect of crude bacterial lipids on the course of listeria infection in mice. Folia Microbiol. 37, 455-460 (1992).
12. MCGHEE J.R., MESTECKY J., DERTZBAUGH M.T., ELDRIDGE J.H., HIRASAWA M., KIYONO H.: The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10, 75-88 (1992).
13. MLČKOVÁ P., ČECHOVÁ D., CHALUPNÁ P., NOVOTNÁ O., PROKEŠOVÁ L.: Enhanced systemic and mucosal antibody responses to a model protein antigen after intranasal and intratracheal immunization using Bacillus firmus as an adjuvant. Immunol.Lett. 77, 39-45 (2001).
14. PROKEŠOVÁ L., NOVÁKOVÁ M., JULÁK J., MÁRA M.: Effect of Bacillus firmus and other sporulating aerobic microorganisms on in vitro stimulation of human lymphocytes. A comparative study. Folia Microbiol. 39, 501-504 (1994).
15. PROKEŠOVÁ L., JULÁK J., NOVÁKOVÁ M., POSPÍŠIL M., MÁRA M.: Polyclonal activation of human lymphocytes by Bacillus firmus and its constituents. Folia Microbiol. 40, 647-651 (1995).
16. PROKEŠOVA L., MLČKOVÁ P., STAŇKOVÁ I., CHLOUBOVÁ A., NOVOTNÁ V., LADMANOVÁ, P., CHALUPNÁ P., MÁRA M.: Effect of Bacillus firmus on antibody formation after mucosal and parenteral immunization in mice. Immunol.Lett. 64, 161-166 (1998).
17. PROKEŠOVÁ L., MLČKOVÁ P., STAŇKOVÁ I., LADMANOVÁ P., JEŽKOVÁ, J., CHALUPNÁ P., NOVOTNÁ O., ČECHOVA D., JULÁK J.: Immuno-stimulatory effect of Bacillus firmus on mouse lymphocytes. Folia Microbiol. 47, 193-197 (2002).
18. RASANEN L., ARVILOMMI H.: Cell walls, peptidoglycans, and teichoic acids of Gram-positive bacteria as polyclonal inducers and immunomodulators of proliferative and lymphokine responses of human B and T lymphocytes. Infect.Immun. 35, 523-527 (1982).
19. H2 cells. Infect.Immun. 67, 6270-6280 (1999).
20. SIMECKA J.W., JACKSON R., KIYONO H., MCGHEE J.R.: Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract. Infect.Immun. 68, 672-679 (2000).
21. ŠTĚPÁNKOVÁ R., MARA M., OČENÁ ŠKOVÁ J.: Prolonged survival of AVN Wistar rats with transplanted Yoshida sarcoma and increase of granular lymphocytes after administration of Bacillus firmus and their crude lipids. Folia Microbiol. 40, 413-416 (1995).
22. STRICKLAND D.H., KEES U.R., HOLT P.G.: Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction. Immunology 87, 250-258 (1996).
23. STUMBLES P.A.: Regulation of T helper cell differentiation by respiratory tract dendritic cells. Immunol.Cell Biol. 77, 428-433 (1999).
24. H1 immunity. J.Exp.Med. 188, 2019-2031 (1998).
25. TAKAHASHI I., MARINARO M., KIYONO H., JACKSON R. J., NAKAGAWA I., FUJIHASHI K., HAMADA S., CLEMENTS J.D., BOST K.L., MCGHEE J.R.: Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli heat-labile enterotoxin. J.Infect.Dis. 173, 627-635 (1996)
26. H2-mediated allergic airway inflammation by an IFN-γ-dependent mechanism. J.Immunol. 166, 1471-1481 (2001).
27. + T cells. J.Immunol. 163, 2592-2600 (1999).
28. UPHAM J.W., STRICKLAND D.H., BILYK N., ROBINSON B.W.S., HOLT P.G.: Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion. Immunology 84, 142-147 (1995).
29. H2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-γ is essential but insufficient. Cell.Immunol. 206, 125-135 (2000).
30. WERLING D., JUNGI T.W.: TOLL-like receptors linking innate and adaptive immune response. Vet.Immunol.Immunopathol. 91, 1-12 (2003).
31. H2 cells in mucosa associated tissues. J.Exp.Med. 178, 1309-1320 (1993).
32. YAMAMOTO S., TAKEDA Y., YAMAMOTO M., KURAZONO H., IMAOKA K., YAMAMOTO M., FUJIHASHI K., NODA M., KIYONO H., MCGHEE J.R.: Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J.Exp.Med. 185, 1203-1210 (1997).
33. ZÍDEK Z., TUČKOVÁ L., MÁRA M., BAROT-CIORBARU R., PROKEŠOVÁ L., TLASKALOVÁ H.: Stimulation of macrophages by Bacillus firmus: production of nitric oxide and cytokines. Internat.J.Immunopharmacol. 20, 359-368 (1998).